Time slot's time in Taipei (GMT+8)
2025/11/23 11:40-12:30 Room 101 AB
- Lunch Symposium-台灣美強股份有限公司 Taiwan Major Chem. & Pharm. Corp.
台灣美強股份有限公司 Taiwan Major Chem. & Pharm. Corp.
- Time
- Topic
- Speaker
- Moderator
- 11:40-12:30
- The Benefits of COMT inhibition for Parkinson’s Disease: The L-Dopa Optimization Treatment Strategies from Opicapone
- Speaker:
Kai-Hsiang Stanley Chen
(Taiwan)
- Moderator:
Tsu-Kung Lin
(Taiwan)
- Tsu-Kung Lin
- MD, PhD
-
Vice Superintendent, Kaohsiung Chang Gung Memorial Hospital
Professor, Kaohsiung Chang Gung Memorial Hospital, Department of Neurology
E-mail：tklin@cgmh.org.tw
Executive Summary：
Dr. Lin received his neurological training at Kaohsiung Chang Gung Memorial Hospital, Taiwan (1989-1994) and completed his PhD at Department of Biochemistry at University of Otago, New Zealand (1998-2002). He was the Chief of Neurology at the Kaohsiung Chang Gung Memorial Hospital, Taiwan from 2011-2017. Currently, he is serve as a Professor at Neurology Department of Kaohsiung Chang Gung Memorial Hospital and Vice superintendent of Kaohsiung Chang Gung Memorial Hospital. His major interests are in mitochondrial dysfunction and oxidative stress in Neurodegenerative diseases.
Dr. Lin received his neurological training at Kaohsiung Chang Gung Memorial Hospital, Taiwan (1989-1994) and completed his PhD at Department of Biochemistry at University of Otago, New Zealand (1998-2002). He was the Chief of Neurology at the Kaohsiung Chang Gung Memorial Hospital, Taiwan from 2011-2017. Currently, he is serve as a Professor at Neurology Department of Kaohsiung Chang Gung Memorial Hospital and Vice superintendent of Kaohsiung Chang Gung Memorial Hospital. His major interests are in mitochondrial dysfunction and oxidative stress in Neurodegenerative diseases.
